Product NDC: | 65862-099 |
Proprietary Name: | Cefprozil |
Non Proprietary Name: | Cefprozil |
Active Ingredient(s): | 125 mg/5mL & nbsp; Cefprozil |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-099 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065381 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070130 |
Package NDC: | 65862-099-01 |
Package Description: | 100 mL in 1 BOTTLE (65862-099-01) |
NDC Code | 65862-099-01 |
Proprietary Name | Cefprozil |
Package Description | 100 mL in 1 BOTTLE (65862-099-01) |
Product NDC | 65862-099 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefprozil |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20070130 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | CEFPROZIL |
Strength Number | 125 |
Strength Unit | mg/5mL |
Pharmaceutical Classes |